An investigation of small children up to two years old with epilepsy resistant to treatment with some anticonvulsant drugs. The study shows that the ketogenic diet, given to children for 8 weeks, has similar efficacy and tolerability to additional anticonvulsant medication; it should therefore be considered a safe treatment option for children of this young age with drug-resistant epilepsy.
For The Lancet Neurology 2023